As of 2024-12-11, the Intrinsic Value of Medmix Ltd (MEDX.SW) is
18.67 CHF. This MEDX.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 8.79 CHF, the upside of Medmix Ltd is
112.50%.
The range of the Intrinsic Value is 9.09 - 70.43 CHF
18.67 CHF
Intrinsic Value
MEDX.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
9.09 - 70.43 |
18.67 |
112.5% |
| DCF (Growth 10y) |
13.29 - 85.85 |
24.71 |
181.1% |
| DCF (EBITDA 5y) |
22.35 - 35.36 |
31.85 |
262.4% |
| DCF (EBITDA 10y) |
23.36 - 39.28 |
33.76 |
284.0% |
| Fair Value |
-0.61 - -0.61 |
-0.61 |
-106.95% |
| P/E |
(0.96) - 8.17 |
3.19 |
-63.7% |
| EV/EBITDA |
17.22 - 30.88 |
24.77 |
181.8% |
| EPV |
9.29 - 15.87 |
12.58 |
43.1% |
| DDM - Stable |
(0.44) - (1.68) |
(1.06) |
-112.0% |
| DDM - Multi |
7.47 - 22.77 |
11.30 |
28.5% |
MEDX.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
358.53 |
| Beta |
0.96 |
| Outstanding shares (mil) |
40.79 |
| Enterprise Value (mil) |
581.73 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.72% |
| Cost of Debt |
5.10% |
| WACC |
6.06% |